Objective: To quantify the potential benefit of adjuvant chemotherapy (ACT) with respect to
survival, and to identify factors for predicting prognoses in early gastric cancer patients …

Background: There is no global consensus on adjuvant chemotherapy (ACT) for pT2N0M0
gastric cancer. We conducted a retrospective study to reveal the role of ACT in such patients …

Purpose Generally, adjuvant chemotherapy (AC) should be initiated as soon as possible
after surgery to eradicate microscopic cancer cells. In this study, we investigated the effect of …

Background Due to a lack of consensus on adjuvant treatments for pT1N1 gastric cancer,
surgeons face a dilemma when deciding treatments for patients with pT1N1 gastric cancer …

Background Limited studies exist comparing clinical outcomes by adjuvant treatment for
pT1N1 gastric cancer. This study compared the disease-free survival (DFS) of patients with …

© 2022 by Turkish Society of Medical Oncology. Objective: Surgery followed by
chemotherapy with or without radiotherapy and perioperative chemotherapy represents the …

Background The efficacy of adjuvant chemotherapy (AC) on survival outcomes of patients
with stage I gastric cancer (GC) after curative resection remains controversial. We aimed to …

Abstract Background Two recent South Korean studies showed adjuvant therapy (AT) was
not associated with improved survival in pT1N1 gastric adenocarcinoma (GAC). We …

Currently, there is still controversy on postoperative adjuvant chemotherapy for node-
negative advanced gastric cancer. Herein, we sought to evaluate the role of postoperative …

Background The influence of adjuvant chemotherapy on the survival of gastric
adenocarcinoma patients in a stage-specific manner is controversial. Methods To further …